Life Sciences & Medicine Active Updated Nov 20, 2026
CAR-T cells reset autoimmune disease
Where it stands as of Nov 20, 2026
CAR-T cell therapy is showing early benefit in autoimmune disease. In a small Mayo Clinic trial of stiff person syndrome, patients walked and worked again after one round of CAR-T cells. These are small early trials, and how long the benefit lasts is not yet known.
The story so far
-
Nov 20, 2026 Latest
The Optimist Daily reported that after one round of CAR-T cells in a small Mayo Clinic trial for stiff person syndrome, Shari St. Germain walked for seven minutes on the treadmill and Jonathan Walden returned to work.
This story moves with the morning letter.
When this question gets a new answer, the page above changes the same morning. Each morning's letter brings the day's progress in science, medicine and beyond. Free, every day.
Free for good. One click to leave.